Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

[Observational cohort studies. Overview and some examples from the field of drug safety].

Holmqvist M, Raaschou P, Neovius M, Askling J.

Lakartidningen. 2013 Jan 16-22;110(3):82-4. Swedish. No abstract available.

PMID:
23424984
[PubMed - indexed for MEDLINE]
2.

The respective roles of controlled clinical trials and cohort monitoring studies in the pre- and postmarketing assessment of drugs.

Vray M, Hamelin B, Jaillon P; Round Table No.2, Giens XX.

Therapie. 2005 Jul-Aug;60(4):339-44, 345-9. English, French.

PMID:
16268434
[PubMed - indexed for MEDLINE]
3.

Using observational cohort data for studying drug effects on pregnancy outcome--methodological considerations.

Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C.

Reprod Toxicol. 2008 Sep;26(1):36-41. doi: 10.1016/j.reprotox.2008.05.064. Epub 2008 Jun 7.

PMID:
18588969
[PubMed - indexed for MEDLINE]
4.

Drug safety studies and measures of effect using the self-controlled case series design.

Wilson K, Hawken S.

Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):108-10. doi: 10.1002/pds.3337. Epub 2012 Aug 22. No abstract available.

PMID:
22915354
[PubMed - indexed for MEDLINE]
5.

When are observational studies as credible as randomised trials?

Vandenbroucke JP.

Lancet. 2004 May 22;363(9422):1728-31. No abstract available.

PMID:
15158638
[PubMed - indexed for MEDLINE]
6.

Combining electronic healthcare databases in Europe to allow for large-scale drug safety monitoring: the EU-ADR Project.

Coloma PM, Schuemie MJ, Trifirò G, Gini R, Herings R, Hippisley-Cox J, Mazzaglia G, Giaquinto C, Corrao G, Pedersen L, van der Lei J, Sturkenboom M; EU-ADR Consortium.

Pharmacoepidemiol Drug Saf. 2011 Jan;20(1):1-11. doi: 10.1002/pds.2053. Epub 2010 Nov 8.

PMID:
21182150
[PubMed - indexed for MEDLINE]
7.

Methods in epidemiology: observational study designs.

DiPietro NA.

Pharmacotherapy. 2010 Oct;30(10):973-84. doi: 10.1592/phco.30.10.973. Review.

PMID:
20874034
[PubMed - indexed for MEDLINE]
8.

Design of the "Thorough QT Study".

Darpo B, Sager P.

Clin Pharmacol Ther. 2008 Apr;83(4):529; author reply 530. No abstract available.

PMID:
18043696
[PubMed - indexed for MEDLINE]
9.

Juvenile animal toxicity study designs to support pediatric drug development.

Cappon GD, Bailey GP, Buschmann J, Feuston MH, Fisher JE, Hew KW, Hoberman AM, Ooshima Y, Stump DG, Hurtt ME.

Birth Defects Res B Dev Reprod Toxicol. 2009 Dec;86(6):463-9. doi: 10.1002/bdrb.20220. Review.

PMID:
20025047
[PubMed - indexed for MEDLINE]
10.

[Assessing adverse reactions in clinical trials].

Harnisch S, Schade-Brittinger C, Rief W.

Dtsch Med Wochenschr. 2012 Jul;137(27):1421-5. doi: 10.1055/s-0032-1305105. Epub 2012 Jun 26. Review. German.

PMID:
22736184
[PubMed - indexed for MEDLINE]
11.

Cultivating cohort studies for observational translational research.

Ransohoff DF.

Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):481-4. doi: 10.1158/1055-9965.EPI-13-0140. Epub 2013 Mar 5.

PMID:
23462919
[PubMed - indexed for MEDLINE]
Free Article
12.

Potential biases in assessing the risks of pharmacotherapy due to mismeasurement of drug exposure.

Leader S, Mallick R.

Clin Ther. 1998 Jan-Feb;20(1):160-8; discussion 158-9. Review.

PMID:
9522112
[PubMed - indexed for MEDLINE]
13.

From randomized controlled trials to observational studies.

Silverman SL.

Am J Med. 2009 Feb;122(2):114-20. doi: 10.1016/j.amjmed.2008.09.030. Review.

PMID:
19185083
[PubMed - indexed for MEDLINE]
14.

[Study designs for the evaluation of drug effects].

Christensen S, Christiansen CF, Sørensen HT.

Ugeskr Laeger. 2009 Mar 2;171(10):799-802. Danish.

PMID:
19265605
[PubMed - indexed for MEDLINE]
15.

Commentary on 'Designs for dose-escalation trials with quantitative responses'.

O'Quigley J.

Stat Med. 2009 Dec 30;28(30):3745-50; discussion 3759-60. doi: 10.1002/sim.3742.

PMID:
19967752
[PubMed - indexed for MEDLINE]
16.

How should we react to adverse drug reactions?

Ferner RE, Beard K.

Postgrad Med J. 2011 Feb;87(1024):81-2. doi: 10.1136/pgmj.2010.105064. No abstract available.

PMID:
21303818
[PubMed - indexed for MEDLINE]
17.

[Discussion on methods of sample size estimation in conducting clinical reevaluation of postmarketing Chinese medicine].

Tian F, Fu Y, Xie Y.

Zhongguo Zhong Yao Za Zhi. 2011 Apr;36(8):1097-102. Chinese.

PMID:
21809593
[PubMed - indexed for MEDLINE]
18.

Operating characteristics of a Simon two-stage phase II clinical trial design incorporating continuous toxicity monitoring.

Ray HE, Rai SN.

Pharm Stat. 2012 Mar-Apr;11(2):170-6. doi: 10.1002/pst.510. Epub 2012 Jan 10.

PMID:
22232063
[PubMed - indexed for MEDLINE]
19.

Observational studies in the era of randomized trials: finding the balance.

Castillo RC, Scharfstein DO, MacKenzie EJ.

J Bone Joint Surg Am. 2012 Jul 18;94 Suppl 1:112-7. doi: 10.2106/JBJS.L.00242.

PMID:
22810460
[PubMed - indexed for MEDLINE]
20.

When a randomised controlled trial is needed to assess drug safety. The case of paediatric ibuprofen.

Mitchell AA, Lesko SM.

Drug Saf. 1995 Jul;13(1):15-24. Review.

PMID:
8527016
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk